Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04324385
Other study ID # SOMFIT01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 9, 2019
Est. completion date April 10, 2019

Study information

Verified date March 2020
Source Compumedics Limited
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To test the accuracy of a non-invasive blood oxygen saturation monitor which is placed on a subject with profound hypoxia.


Description:

A radial arterial cannula was placed in either the left or right wrist of each subject for arterial blood sampling and blood pressure monitoring. Blood gas analysis to determine oxyhemoglobin saturation (SaO2)was performed using an ABL-90 multi-wavelength oximeter (Hemoximeter, Radiometer, Copenhagen, serial 1393-090R0359N0002). This instrument contains factory certified calibration standards and quality control algorithms.

Each subject had two control blood samples taken at the beginning of each experiment, while breathing room air. Hypoxia was then induced to different and stable levels of oxyhemoglobin saturation (between 70-100%) by having subjects breathe mixtures of nitrogen, room air, and carbon dioxide. Each plateau level of oxyhemoglobin saturation was maintained for at least 30 seconds or until reference pulse oximeters readings were stable. Two arterial blood samples were then obtained, approximately 30 seconds apart. Each stable plateau therefore was maintained for at least 60 seconds with SpO2 fluctuating by less than 2-3%. The plateaus were nominally at 100%, room air saturation, 93%, 90%, 87%, 85%, 82%, 80%, 77%, 75% and 70%. A total of 270 samples were obtained at the saturation plateaus across this span. Data were provided for analysis. At least 200 data points were collected for each type of oximeter and probe combination studied.

Pulse oximeter data is taken as 5 second averages corresponding to the point of arterial blood analysis. Individual data points may be missed or excluded for dropped signals or failure of the oximeter signal to achieve an appropriate plateau. Data is plotted as Hemoximeter data (SaO2) vs. pulse oximeter bias (SpO2 - SaO2). A different marker is used for each study subject. Linear regression is shown for all subjects combined, and the equation with R2 is shown on the plot. Mean bias is displayed as a solid horizontal line, and the upper and lower limits of agreement (mean bias ± 1.96•SD*) are shown by dashed horizontal lines. For the "pooled" plots, different markers are used for each pulse oximeter. Tables of mean, standard deviation, standard error, minimum, maximum, 95% confidence interval, count and root mean square are provided for each oximeter's bias, and all oximeters combined in the following ranges of SaO2 (Hemoximeter): 60 - 80%, 80 - 100%, 60 - 100%, 70 - 100%, 50 - 60%, 60 - 70%, 70 - 80%, 80 -90%, and 90 - 100%.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date April 10, 2019
Est. primary completion date April 10, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 49 Years
Eligibility Inclusion Criteria:

- Normal hemoglobin levels (Hemoglobin = 10gm•dl-1)

- Healthy

- Non-smoking individuals

- 21-49

Exclusion Criteria:

- Unhealthy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Hypoxia Lab San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
Compumedics Limited

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Testing the accuracy of a new pulse oximeter device The primary outcome measure was to find the agreement between methods of measurement with multiple observations per individual. Spo2 readings from the test device were compared with a factory certified and calibrated oxyhemoglobin saturation monitor (i.e. ABL-90 multi-wavelength oxiemter) and two other standard oximeter devices using root mean squared error as the measure of accuracy. Approx. 60 mins per subject
See also
  Status Clinical Trial Phase
Completed NCT01530360 - Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants Phase 1
Completed NCT03710980 - Accuracy of Pulse Oximeters With Profound Hypoxia
Recruiting NCT06015204 - Assessment of the C8 Dermatomal Block With Photoplethysmographic Amplitude After Interscalene Brachial Plexus Block N/A
Completed NCT03250065 - The Sensing ET Tube N/A
Completed NCT04380389 - Accuracy of ScanWatch Pulse Oximeter With Profound Hypoxia N/A
Completed NCT04562584 - Pulse Oximeter Hypoxia N/A
Recruiting NCT04587921 - Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19 N/A
Completed NCT04964609 - EmbracePlus SpO2 Accuracy Validation N/A
Completed NCT03710993 - Accuracy Assessment of Beddr Oximeter
Completed NCT03534271 - The Accuracy of Smartphone Pulse Oximetry in Patients Visiting an Outpatient Pulmonary Function Lab for a 6-Minute Walk Test